Daily Anesthesiology Research Analysis
Analyzed 52 papers and selected 3 impactful papers.
Summary
Three impactful anesthesiology/critical care studies stood out today: a prospective multicenter study integrating immune and endothelial profiling to predict 90-day mortality in postoperative sepsis; a multicenter randomized trial showing that combining short- and long-acting peripheral nerve blocks speeds motor recovery after distal radius fracture surgery without sacrificing analgesia; and a randomized trial demonstrating that esketamine-propofol anesthesia for fiberoptic bronchoscopy improves hemodynamic stability but increases airway adverse events and prolongs recovery.
Research Themes
- Immune-endothelial phenotyping for perioperative sepsis risk stratification
- Regional anesthesia strategies optimizing recovery and analgesia
- Sedation regimen trade-offs for airway safety versus hemodynamic stability
Selected Articles
1. Integrated immune and endothelial profiling predicts 90-day mortality in postoperative sepsis and septic shock.
In a prospective multicenter cohort of 219 postoperative ICU patients, high-dimensional spectral flow cytometry with UMAP/FlowSOM identified immune and endothelial cell subsets associated with 90-day mortality. A LASSO-Cox–derived cellular risk score integrating these features improved prognostic stratification compared with SOFA and APACHE II, with findings supported by validation using public single-cell RNA datasets.
Impact: This study advances precision prognostication in postoperative sepsis by integrating immune and endothelial phenotypes into a validated cellular risk score that outperforms conventional severity indices.
Clinical Implications: If externally validated and operationalized, the cellular risk score could guide early triage, monitoring intensity, and immunomodulatory or endothelial-targeted interventions in postoperative sepsis.
Key Findings
- Prospective multicenter profiling (N=219) identified specific immune and endothelial subsets linked to 90-day mortality.
- A LASSO-Cox–derived cellular risk score improved prognostic discrimination versus SOFA and APACHE II.
- Unsupervised UMAP/FlowSOM analyses and external validation with public scRNA datasets supported robustness.
Methodological Strengths
- Prospective multicenter design with standardized high-dimensional spectral flow cytometry
- Advanced analytics (UMAP/FlowSOM, LASSO-Cox) and validation using external single-cell datasets
Limitations
- Moderate sample size and single prospective cohort may limit generalizability
- Prognostic score requires external, prospective validation and clinical workflow integration
Future Directions: Prospective external validation across diverse centers, integration into decision-support systems, and interventional trials targeting identified immune-endothelial axes.
BACKGROUND: Sepsis and septic shock remain major causes of mortality in critically ill postoperative patients, largely because of the lack of reliable biomarkers for early risk stratification. The interplay between immune dysfunction and endothelial activation is key in the progression to multiorgan failure, however phenotypic characterisation of circulating endothelial subpopulations remains limited. METHODS: A Prospective multicentre study included 219 postoperative patients (Non-septic ICU patients, sepsis, septic shock). Peripheral Blood Mononuclear Cells were analysed using high-di
2. Enhanced Recovery after Distal Radius Fracture Surgery using Combined Short- and Long-Acting Nerve Blocks: a Randomized Controlled Trial.
In 128 analyzed patients, combining a short-acting axillary block with long-acting median and radial nerve blocks produced similar pain at motor block resolution but significantly faster motor recovery (median 4 vs 15 hours). Opioid use and severe pain incidence were comparable, and block success rates were high in both groups.
Impact: Demonstrates a practical regional anesthesia strategy that accelerates functional recovery while maintaining analgesia, with direct implications for ambulatory orthopedic anesthesia.
Clinical Implications: Adopting a short-acting axillary plus long-acting elbow truncal block approach can reduce motor blockade duration and facilitate early mobilization and discharge without compromising pain control.
Key Findings
- Pain at motor block resolution was similar between groups (mean 2.18 ± 2.35 vs 2.49 ± 3.22; mean difference 0.31, 95% CI -0.69 to 1.31).
- Motor block recovery was significantly shorter with the combined approach (median 4 [2-6] vs 15 [10-19] hours; P < 0.001).
- Opioid consumption and severe pain incidence did not differ; block success rates were 91% vs 98% (P = 0.08).
Methodological Strengths
- Multicenter randomized controlled equivalence design with registered protocol (NCT04046744)
- Clinically meaningful outcomes including pain at block resolution and motor recovery time
Limitations
- Open-label design may introduce performance bias
- Equivalence was not formally concluded for the primary pain outcome
Future Directions: Confirmatory blinded trials with standardized local anesthetic dosing and inclusion of functional recovery and patient-reported outcomes across ambulatory settings.
BACKGROUND: Distal radius fractures are commonly treated under regional anesthesia; however, conventional approaches face limitations, including prolonged motor block with long-acting agents and pain rebound with short-acting agents. OBJECTIVE: To investigate whether combining a short-acting axillary block with long-acting truncal blocks at the elbow (median and radial nerves) is equivalent to a long-acting axillary block alone for postoperative pain management after distal radius fracture surgery. STUDY DESIGN: Multicenter, prospective, randomized, open-label, parallel-group, controlled, equivalen
3. Comparison of Esketamine and Remifentanil Combined With Propofol for Painless Fiberoptic Bronchoscopy: A Randomized Controlled Trial.
Among 206 randomized patients, esketamine-propofol anesthesia yielded better hemodynamic stability (fewer hypotension/bradycardia events and higher SBP/DBP/HR) but significantly more airway adverse events (bronchospasm 47.1% vs 29.4%; greater airway secretions), required higher propofol doses, and prolonged recovery time compared with remifentanil-propofol.
Impact: Directly informs anesthetic regimen selection for bronchoscopy by quantifying airway safety trade-offs against hemodynamic stability with esketamine versus remifentanil.
Clinical Implications: Esketamine-based regimens may be preferable in patients at high risk of hypotension/bradycardia but warrant caution due to increased bronchospasm and secretions; proactive airway management and tailored dosing are essential.
Key Findings
- Bronchospasm occurred more often with esketamine (47.12%) than remifentanil (29.41%, P=0.003); airway secretions grade 2 were 76.92% vs 33.33%.
- Esketamine group required higher propofol doses (300.01 ± 151.81 mg vs 142.62 ± 66.72 mg) and had prolonged recovery time (P < 0.05).
- Hemodynamic profile favored esketamine (higher SBP/DBP/HR at T3–T5; fewer hypotension and bradycardia events), with no differences in pain scores, satisfaction, procedure duration, or discharge time.
Methodological Strengths
- Randomized controlled design with adequate sample size (N=206)
- Standardized anesthetic protocols enabling direct comparison of safety and efficacy
Limitations
- Blinding not described, introducing potential assessment bias
- Single-setting protocol may limit generalizability to other bronchoscopy practices
Future Directions: Blinded multicenter trials stratifying airway reactivity risk, optimizing dosing, and incorporating adjuncts (anticholinergics/antisialagogues) to mitigate airway events with esketamine.
PURPOSE: This randomized controlled trial was designed to compare the efficacy and safety of esketamine versus remifentanil respectively combined with propofol for painless fiberoptic bronchoscopy (FFB). METHODS: A total of 206 patients undergoing elective painless FFB were randomly divided into 2 groups. The experimental group (n = 104) received anesthesia induction with esketamine 0.5 mg/kg, propofol 2 to 3 mg/kg, and rocuronium 0.3 mg/kg, followed by maintenance with esketamine 0.5 to 3 mg·kg FINDINGS: Compared with the control group, the experimental group had a significantly higher incidence of bronchospasm (47.12% vs. 29.41%, P = 0.003), and a significantly higher proportion of patients with grade 2 airway secretions (76.92% vs. 33.33%), higher propofol dosage (300.01 ± 151.81 mg vs. 142.62 ± 66.72 mg), elevated SBP/DBP/HR at T3-T5, increased airway pressure at T4-T5, higher incidences of hypertension, lower incidences of hypotension and bradycardia, reduced grade 0 cough scores, increased grade 5 cough scores, decreased grade 0 to 1 sputum volume, increased grade 4 sputum volume, and prolonged recovery time (all P < 0.05). No significant differences were observed in airway stenosis grade, bronchial mucosal swelling/congestion, other adverse events, NRS pain score, operator/anesthesiologist satisfaction, operation duration, or discharge time (all P > 0.05). IMPLICATIONS: In this study of adult patients undergoing elective painless flexible fiberoptic bronchoscopy, esketamine was associated with better hemodynamic stability but increased risks of airway adverse events and prolonged recovery time, requiring vigilant perioperative management in appropriately selected patients.